Ingestion of Caustic Substances.
Hoffman RS, Burns MM, Gosselin S.
N Engl J Med. 2020 Apr 30;382(18):1739-1748. doi: 10.1056/NEJMra1810769.
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.
Wallace KB, Sardão VA, Oliveira PJ.
Circ Res. 2020 Mar 27;126(7):926-941. doi: 10.1161/CIRCRESAHA.119.314681. Epub 2020 Mar 26.
Sensing steroid hormone 17α-hydroxypregnenolone by GPR56 enables protection from ferroptosis-induced liver injury.
Lin H, Ma C, Zhuang X, Liu S, Liu D, Zhang M, Lu Y, Zhou G, Zhang C, Wang T, Zhang Z, Lv L, Zhang D, Ruan XZ, Xu Y, Chai R, Yu X, Sun JP, Chu B.
Cell Metab. 2024 Nov 5;36(11):2402-2418.e10. doi: 10.1016/j.cmet.2024.09.007. Epub 2024 Oct 9.
Toxin-Induced Subacute Encephalopathy.
Lerner DP, Tadevosyan A, Burns JD.
Neurol Clin. 2020 Nov;38(4):799-824. doi: 10.1016/j.ncl.2020.07.006.
Drug-induced cardiomyopathies.
Buja LM, Ferrans VJ, Roberts WC.
Adv Cardiol. 1974;13:330-48. doi: 10.1159/000395545.
Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis.
Hu S, Tang B, Lu C, Wang S, Wu L, Lei Y, Tang L, Zhu H, Wang D, Yang S.
Pharmacol Res. 2024 Aug;206:107275. doi: 10.1016/j.phrs.2024.107275. Epub 2024 Jun 20.
Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.
Tevyashova AN, Olsufyeva EN, Balzarini J, Shtil AA, Dezhenkova LG, Bukhman VM, Zbarsky VB, Preobrazhenskaya MN.
J Antibiot (Tokyo). 2009 Jan;62(1):37-41. doi: 10.1038/ja.2008.7. Epub 2009 Jan 9.
Drug-Induced Liver Injury-Pharmacological Spectrum Among Children.
Maris BR, Grama A, Pop TL.
Int J Mol Sci. 2025 Feb 25;26(5):2006. doi: 10.3390/ijms26052006.
Biochemical pathology.
Farber E.
Annu Rev Pharmacol. 1971;11:71-96. doi: 10.1146/annurev.pa.11.040171.000443.
A Review on the Neurotoxic Effects of Doxorubicin.
Kamińska K, Cudnoch-Jędrzejewska A.
Neurotox Res. 2023 Oct;41(5):383-397. doi: 10.1007/s12640-023-00652-5. Epub 2023 Jun 23.
